219 related articles for article (PubMed ID: 25914047)
1. Prognostic role of Oct4, CD44 and c-Myc in radio-chemo-resistant oral cancer patients and their tumourigenic potential in immunodeficient mice.
Sawant S; Gokulan R; Dongre H; Vaidya M; Chaukar D; Prabhash K; Ingle A; Joshi S; Dange P; Joshi S; Singh AK; Makani V; Sharma S; Jeyaram A; Kane S; D'Cruz A
Clin Oral Investig; 2016 Jan; 20(1):43-56. PubMed ID: 25914047
[TBL] [Abstract][Full Text] [Related]
2. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
[TBL] [Abstract][Full Text] [Related]
3. CD44+/CD133+ immunophenotype and matrix metalloproteinase-9: Influence on prognosis in early-stage oral squamous cell carcinoma.
Oliveira LR; Castilho-Fernandes A; Oliveira-Costa JP; Soares FA; Zucoloto S; Ribeiro-Silva A
Head Neck; 2014 Dec; 36(12):1718-26. PubMed ID: 24178866
[TBL] [Abstract][Full Text] [Related]
4. Increased Expression of Oct4, Nanog and CD24 Predicts Poor Response to Chemo-Radiotherapy and Unfavourable Prognosis in Locally Advanced Oral Squamous Cell Carcinoma.
Mishra S; Tiwari V; Arora A; Gupta S; Anand N; Husain N
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2539-2547. PubMed ID: 32986350
[TBL] [Abstract][Full Text] [Related]
5. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
Kosunen A; Pirinen R; Ropponen K; Pukkila M; Kellokoski J; Virtaniemi J; Sironen R; Juhola M; Kumpulainen E; Johansson R; Nuutinen J; Kosma VM
Oral Oncol; 2007 Jan; 43(1):51-9. PubMed ID: 16798062
[TBL] [Abstract][Full Text] [Related]
6. CD44+ cancer cell-induced metastasis: A feasible neck metastasis model.
Wu TF; Chen L; Bu LL; Gao J; Zhang WF; Jia J
Eur J Pharm Sci; 2017 Apr; 101():243-250. PubMed ID: 28215944
[TBL] [Abstract][Full Text] [Related]
7. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Rao RS; Raju K L; Augustine D; Patil S
Cancer Control; 2020; 27(1):1073274820904959. PubMed ID: 32951453
[TBL] [Abstract][Full Text] [Related]
9. Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parameters.
Saghravanian N; Anvari K; Ghazi N; Memar B; Shahsavari M; Aghaee MA
Arch Oral Biol; 2017 Oct; 82():160-165. PubMed ID: 28645102
[TBL] [Abstract][Full Text] [Related]
10. Breast tumour cell subpopulations with expression of the MYC and OCT4 proteins.
Litviakov NV; Bychkov VA; Stakheeva MN; Ibragimova MK; Tsyganov MM; Gaptulbarova KA; Tashireva LA; Bondar LN; Garbukov EY; Slonimskaya EM
J Mol Histol; 2020 Dec; 51(6):717-728. PubMed ID: 33037978
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
Chen Y; Song J; Jiang Y; Yu C; Ma Z
Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of CD44, NANOG, OCT4, and BMI1 expression in tongue squamous cell carcinoma.
Rodrigues MFSD; Xavier FCA; Andrade NP; Lopes C; Miguita Luiz L; Sedassari BT; Ibarra AMC; López RVM; Kliemann Schmerling C; Moyses RA; Tajara da Silva EE; Nunes FD
Head Neck; 2018 Aug; 40(8):1759-1773. PubMed ID: 29607565
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cell markers in patterning differentiation and in prognosis of oral squamous cell carcinoma.
Mohanta S; Siddappa G; Valiyaveedan SG; Dodda Thimmasandra Ramanjanappa R; Das D; Pandian R; Khora SS; Kuriakose MA; Suresh A
Tumour Biol; 2017 Jun; 39(6):1010428317703656. PubMed ID: 28631562
[TBL] [Abstract][Full Text] [Related]
14. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.
Ghuwalewala S; Ghatak D; Das P; Dey S; Sarkar S; Alam N; Panda CK; Roychoudhury S
Stem Cell Res; 2016 Mar; 16(2):405-17. PubMed ID: 26926234
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of CD44 expression in oral squamous cell carcinoma: A meta-analysis.
Mirhashemi M; Sadeghi M; Ghazi N; Saghravanian N; Dehghani M; Aminian A
Ann Diagn Pathol; 2023 Dec; 67():152213. PubMed ID: 37856951
[TBL] [Abstract][Full Text] [Related]
16. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
[TBL] [Abstract][Full Text] [Related]
17. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
[TBL] [Abstract][Full Text] [Related]
18. High CD44 Immunoexpression Correlates with Poor Overall Survival: Assessing the Role of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma Patients from the High-Risk Population of Pakistan.
Adnan Y; Ali SMA; Farooqui HA; Kayani HA; Idrees R; Awan MS
Int J Surg Oncol; 2022; 2022():9990489. PubMed ID: 35296132
[TBL] [Abstract][Full Text] [Related]
19. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.
You L; Guo X; Huang Y
Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
